Definition:
Anaemia is the commonest haematological disorder seen in general medical practice
It is defined as haemoglobin concentration below the lower limit of normal for relevant population and laboratory performing test:
Risk Factors
Risk factors are extremes of age, being female, pregnant or lactating. Although anaemia itself may cause morbidity, in the majority of cases it is secondary to an underlying disorder.
Investigations
Investigations should be aimed at identifying a possible cause before treatment or referral is considered. See Before Referral section below.
Iron Deficiency Anaemia
Please also see the Anaemia (Iron Deficiency) page for specific advice on investigation and management of Iron Deficiency Anaemia (IDA) and Non Anaemic Iron Deficiency (NAID).
Haematology referral is unlikely to be suitable for:
Consider referral for other conditions based on the advice in the Red Flag section below.
Refer via Haematology 2WW pathways as follows:
Urgency of referral will vary depending on various factors including degree of anaemia, rapidity of progression and presence of associated features, as well as frailty of patient.
General Assessment points in Primary Care
Microcytosis/Microcytic anaemia:
The cause is often iron deficiency but may be thalassaemia / thalassaemia trait or anaemia of chronic disease.
Check for iron deficiency:
See the Anaemia (Iron Deficiency) page.
Ferritin results can be difficult to interpret - a ferritin below the reference range is diagnostic of iron deficiency. However iron deficiency can still exist with a normal ferritin especially if there is infection or inflammation present. Ferritin levels increase independently of iron status in acute and chronic inflammatory conditions, malignant disease, and liver disease.
If ferritin < 100ug/l this could still be iron deficiency especially if an inflammatory condition, malignancy or liver disease is present in these patients:
Other causes of microcytosis:
Normocytic anaemia:
Macrocytosis/macrocytic anaemia - see also the Macrocytosis page.
Treatment is dependent on the underlying cause but management of symptomatic patients while awaiting investigation may be required.
Generally, healthy individuals tolerate extreme anaemia well, with cardiovascular status being the major limiting factor. In haemodynamically stable patients without active bleeding, Hb levels between 70 g/L and 90 g/L were well tolerated with equivalent or lower mortality/morbidity outcomes compared with a liberal transfusion trigger of <100 g/L. It is generally recommended that determination of transfusion requirements be based upon severity of illness parameters rather than arbitrary Hb levels.
Blood transfusion
If transfusion support for symptomatic care is considered appropriate direct arrangements with local Medical Day Care / Ambulatory Care facility may be made. Please see Blood Transfusions and iron infusionspage of Remedy.
Iron replacement
If a patient has iron deficiency anaemia then consider iron replacement if required (while investigations of cause are completed). See the Anaemia (Iron Deficiency) page for details.
Referral should be made depending on initial investigations in primary care and likely underlying cause.
If haematology advice or referral is required then please consider the following options:
URGENT ADVICE: 9am to 5pm via hospital switchboard for haematology SpR. ONLY for emergency advice. Out of hours and weekends – emergency advice may be obtained from the on-call haematology clinician via hospital switchboard.
NON-URGENT ADVICE: use the Haematology advice and guidance service via eRS. Your query should be responded to by a consultant haematologist within 5 working days. Please only use this service once the guidelines above have been followed and include relevant information and investigation results.
OUTPATIENT REFERRAL: via e-RS if appropriate or following advice and guidance.
SUSPECTED CANCER (2WW) : See Haematology - USC (2WW) page and/or red flags above. Ensure that the location and size of any lymphadenopathy is described.
Minimal information: the referral letter should include abnormal clinical findings (location, size, any associated features) and any abnormal full blood count results or other relevant test results, particularly if these investigations were not done in laboratories of the hospital to which the referral is made.
Patient information
Efforts are made to ensure the accuracy and agreement of these guidelines, including any content uploaded, referred to or linked to from the system. However, BNSSG ICB cannot guarantee this. This guidance does not override the individual responsibility of healthcare professionals to make decisions appropriate to the circumstances of the individual patient, in consultation with the patient and/or guardian or carer, in accordance with the mental capacity act, and informed by the summary of product characteristics of any drugs they are considering. Practitioners are required to perform their duties in accordance with the law and their regulators and nothing in this guidance should be interpreted in a way that would be inconsistent with compliance with those duties.
Information provided through Remedy is continually updated so please be aware any printed copies may quickly become out of date.